The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 43 | 93.2x | 20.1x | Near average | |
Growth | 47 | 7.9% | 5.6% | Near average | |
Quality | 40 | 1.9% | 7.6% | Near average | |
Safety | 70 | -2.3x | 0.4x | Above average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Omnicell, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Omnicell, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Omnicell stock shows a state of complete stability in the average price targets at 57.2 dollars over the past thirty days, with a notable price gap between the high (70 dollars) and the low (49 dollars). This dispersion indicates uncertainty among analysts regarding the speed of operating margin recovery, even though the current price (44.41 dollars) is trading below the lowest expectations, which may suggest excessive pessimism by the market or a wait for tangible growth catalysts.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.